Drug-resistant enteric fever in the UK

Lancet

Volumn 367, Issue 9522, 2006, Pages 1576-

  Threlfall, EJ ^a   Day, M ^a   de Pinna, E ^a   Lewis, H ^a   Lawrence, J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; HUMAN; HYGIENE; LETTER; PRIORITY JOURNAL; SALMONELLA ENTERICA; TYPHOID FEVER; VACCINATION;

EID: 33646367411     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68691-1     Document Type: Letter

References (5)

1. Rowe B., Ward L., and Threlfall E. Spread of multiresistant typhoid fever. Lancet 336 (1990) 1065-1066
2. Umansanker S., Wall R., and Berger J. A case of ciprofloxacin-resistant typhoid fever. Commun Dis Rev 2 (1992) R139-R140
3. Threlfall E., Ward L., Skinner J., Smith H., and Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 353 (1999) 1590-1591
4. Threlfall E., Skinner J., and Ward L. Detection of decreased susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J Antimicrob Chemother 48 (2001) 740-741
5. Lewis H., and Lawrence J. Recent increase in S. paratyphi A phage type 1 and S. Typhi Vi-phage type E1 in England and Wales, associated with travel to the Indian subcontinent. Eurosurveillance 11 (2006) 7-10. http://www.eurosurveillance.org/w/2006/060309.asp#4 (accessed April 10, 2006)